1. Microembolic signals in systemic lupus erythematosus and other cerebral small vessel diseases

   • José Fidel Baizabal-Carvallo
   • Yves Samson

   Review 24 December 2009 Pages: 503 - 508

2. Antibodies and neuronal autoimmune disorders of the CNS

   • Francesc Graus
   • Albert Saiz
   • Josep Dalmau

   Review 25 December 2009 Pages: 509 - 517

3. A comparison of three measures of upper limb function in Friedreich ataxia

   • L. A. Corben
   • G. Tai
   • M. B. Delatycki

   Original Communication 13 October 2009 Pages: 518 - 523

4. Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression

   • Sven Pålhagen
   • Hongshi Qi
   • Per Svenningsson

   Original Communication 21 October 2009 Pages: 524 - 532

   

5. An exploration of ocular fixation in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy

   • Ralph Allen Pinnock
   • Richard Canice McGivern
   • James Mark Gibson

   Original Communication 22 October 2009 Pages: 533 - 539

   

6. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease

   • Paula Scalzo
   • Arthur Kümmer
   • Antônio Lúcio Teixeira

   Original Communication 22 October 2009 Pages: 540 - 545

   

7. Enhanced muscle shortening and impaired Ca²⁺ channel function in an acute septic myopathy model

   • Oliver Friedrich
   • Ernst Hund
   • Frederic von Wegner

   Original Paper 04 November 2009 Pages: 546 - 555

   

8. Vasomotor properties of the M2 segment of the middle cerebral artery

   • Semai Bek
   • Tayfun Kaşikçi
   • Zeki Odabaşi

   Original Communication 05 November 2009 Pages: 556 - 562

   

9. Incidence and risk factors for seizures after heart transplantation

   • Vincent Navarro
   • Shaida Varnous
   • Michel Baulac

   Original Communication 06 November 2009 Pages: 563 - 568

   

10. Apraxia in progressive nonfluent aphasia

    • Jonathan Daniel Rohrer
    • Martin N. Rossor
    • Jason D. Warren

    Original Communication Open access 12 November 2009 Pages: 569 - 574

    

11. The first Italian family with tibial muscular dystrophy caused by a novel titin mutation

    • Marzia Pollazzon
    • Tiina Suominen
    • Bjarne Udd

    Original Communication 13 November 2009 Pages: 575 - 579

    

12. Parenthood and immunomodulation in patients with multiple sclerosis

    • Kerstin Hellwig
    • Aiden Haghikia
    • Ralf Gold

    Original Communication 21 November 2009 Pages: 580 - 583

    

13. Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a

    • Peter Joseph Jongen
    • Christian Sindic
    • The Functional composite and quality of Life in Avonex-treated Relapsing multiple sclerosis patients (FLAIR) study group

    Original Communication 18 November 2009 Pages: 584 - 589

14. Altered callosal function in cerebral microangiopathy

    • Matthias Wittstock
    • Annette Grossmann
    • Alexander Wolters

    Original Communication 16 November 2009 Pages: 590 - 597

    

15. The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia

    • Pia Irene Anna Rossi
    • Carlotta Maria Vaccari
    • Aldamaria Puliti

    Original Communication 19 November 2009 Pages: 598 - 602

16. Transient gender-related effects in Parkinson’s disease patients with subthalamic stimulation

    • Luigi Michele Romito
    • Fiorella Maria Contarino
    • Alberto Albanese

    Original Communication 18 November 2009 Pages: 603 - 608

17. CSF phospho-tau is independent of age, cognitive status and gender of neurological patients

    • Armin Scheurich
    • Peter P. Urban
    • Andreas Fellgiebel

    Original Communication 17 November 2009 Pages: 609 - 614

18. Blood–brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndrome

    • Sebastian Ivens
    • Szendro Gabriel
    • Ilan Shelef

    Original Communication 22 November 2009 Pages: 615 - 620

    

19. Motor-dominant chronic inflammatory demyelinating polyneuropathy

    • Akio Kimura
    • Takeo Sakurai
    • Takashi Inuzuka

    Original Communication 22 November 2009 Pages: 621 - 629

    

20. How predictive is the MMSE for cognitive performance after stroke?

    • Ariane Bour
    • Sascha Rasquin
    • Frans Verhey

    Original Communication Open access 22 November 2009 Pages: 630 - 637

    

21. Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study

    • Yaroslav Winter
    • Sonja von Campenhausen
    • Werner Poewe

    Original Communication 28 November 2009 Pages: 638 - 645

    

22. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey

    • Matthias Boentert
    • Rainer Dziewas
    • Peter Young

    Original Communication Open access 24 November 2009 Pages: 646 - 652

23. Pasteurella multocida meningitis caused by kissing animals: a case report and review of the literature

    • Shoji Kawashima
    • Noriyuki Matsukawa
    • Kosei Ojika

    Letter to the editors 10 December 2009 Pages: 653 - 654

24. Successful treatment with rituximab of one patient with CANOMAD neuropathy

    • Emilien Delmont
    • P. Y. Jeandel
    • C. Desnuelle

    Letter to the Editors 04 December 2009 Pages: 655 - 657

25. Autosomal dominant nemaline myopathy caused by a novel α-tropomyosin 3 mutation

    • I. C. Kiphuth
    • S. Krause
    • R. Schröder

    Letter to the Editors 10 December 2009 Pages: 658 - 660

    

26. Nigropallidal iron accumulation in pantothenate kinase-associated neurodegeneration demonstrated by susceptibility-weighted imaging

    • Jae-Hyeok Lee
    • Dae-Seong Kim
    • Sang-Ook Nam

    Letter to the Editors 05 December 2009 Pages: 661 - 662

    

27. Posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria

    • Sa-Yoon Kang
    • Ji-Hoon Kang
    • Jung Seok Lee

    Letter to the editors 11 December 2009 Pages: 663 - 664

    

28. Dissociation between the severity of cerebrospinal fluid hypovolemia and MRI findings

    • Masaaki Matsushima
    • Ichiro Yabe
    • Hidenao Sasaki

    Letter to the editors 11 December 2009 Pages: 665 - 666

    

29. Prevalence of MS in Iranian Immigrants to British Columbia, Canada

    • Colleen Guimond
    • David A. Dyment
    • A. Dessa Sadovnick

    Letter to the editors 10 December 2009 Pages: 667 - 668

30. Amnestic syndrome due to meningovascular neurosyphilis

    • H. Kearney
    • P. Mallon
    • K. O’Rourke

    Letter to the editors 09 December 2009 Pages: 669 - 671

    

31. Arachnoiditis and communicating hydrocephalus as a complication of epidural blood patch

    • Nadia Al Maach
    • O. J. M. Vogels
    • P. H. Wessels

    Letter to the editors 24 December 2009 Pages: 672 - 673

    

32. Sildenafil improves scotoma after posterior cerebral infarctions: a case report

    • Peter Schlindwein
    • B. M. Eicke
    • M. Dieterich

    Letter to the editors 27 December 2009 Pages: 674 - 677

    

33. Multiple cerebral infarctions in a patient with Churg-Strauss syndrome

    • Leyli Ghaeni
    • Eberhard Siebert
    • Uwe Reuter

    Letter to the editors 03 January 2010 Pages: 678 - 680

    

34. Claude François Lallemand (1790–1854)

    • Jacques Poirier

    Pioneers in Neurology 17 February 2010 Pages: 681 - 682

    

35. News on treatment: from antiepileptics in childhood absence epilepsy to improvement of falls in Parkinson’s disease by deep brain stimulation

    • Michael Strupp

    Journal Club 19 March 2010 Pages: 683 - 685

36. Erratum to: The first Italian family with tibial muscular dystrophy caused by a novel titin mutation

    • Marzia Pollazzon
    • Tiina Suominen
    • Bjarne Udd

    Erratum 18 December 2009 Pages: 686 - 686

37. ENS Communications

    • Heinz Reichmann

    ENS Communications 27 March 2010 Pages: 687 - 690